Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Search-and-replace genome editing without double-strand breaks or donor DNA
20192.9k citationsAndrew V. Anzalone, Peyton B. Randolph et al.Natureprofile →
Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction
2018662 citationsLuke W. Koblan, Jordan L. Doman et al.Nature Biotechnologyprofile →
Prime genome editing in rice and wheat
2020556 citationsQiupeng Lin, Yuan Zong et al.Nature Biotechnologyprofile →
A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing
2020483 citationsBeverly Mok, Marcos H. de Moraes et al.Natureprofile →
Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins
2022397 citationsSamagya Banskota, Aditya Raguram et al.Cellprofile →
Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing
2021376 citationsAndrew V. Anzalone, Xin D. Gao et al.Nature Biotechnologyprofile →
Therapeutic in vivo delivery of gene editing agents
2022318 citationsAditya Raguram, Samagya Banskota et al.Cellprofile →
Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors
2020312 citationsJordan L. Doman, Aditya Raguram et al.Nature Biotechnologyprofile →
Phage-assisted evolution and protein engineering yield compact, efficient prime editors
2023161 citationsJordan L. Doman, Smriti Pandey et al.Cellprofile →
Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity
2022156 citationsMonica E. Neugebauer, Alvin Hsu et al.Nature Biotechnologyprofile →
CRISPR-free base editors with enhanced activity and expanded targeting scope in mitochondrial and nuclear DNA
2022131 citationsBeverly Mok, Anna V. Kotrys et al.Nature Biotechnologyprofile →
Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo
2024128 citationsMeirui An, Aditya Raguram et al.Nature Biotechnologyprofile →
Efficient in vivo base editing via single adeno-associated viruses with size-optimized genomes encoding compact adenine base editors
2022117 citationsJessie R. Davis, Xiao Wang et al.Nature Biomedical Engineeringprofile →
Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice
2023106 citationsDaniel Reichart, Gregory A. Newby et al.Nature Medicineprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Aditya Raguram
Since
Specialization
Citations
This map shows the geographic impact of Aditya Raguram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aditya Raguram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aditya Raguram more than expected).
This network shows the impact of papers produced by Aditya Raguram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aditya Raguram. The network helps show where Aditya Raguram may publish in the future.
Co-authorship network of co-authors of Aditya Raguram
This figure shows the co-authorship network connecting the top 25 collaborators of Aditya Raguram.
A scholar is included among the top collaborators of Aditya Raguram based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Aditya Raguram. Aditya Raguram is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
An, Meirui, Aditya Raguram, Samuel W. Du, et al.. (2024). Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo. Nature Biotechnology. 42(10). 1526–1537.128 indexed citations breakdown →
Reichart, Daniel, Gregory A. Newby, Hiroko Wakimoto, et al.. (2023). Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice. Nature Medicine. 29(2). 412–421.106 indexed citations breakdown →
6.
Doman, Jordan L., Smriti Pandey, Monica E. Neugebauer, et al.. (2023). Phage-assisted evolution and protein engineering yield compact, efficient prime editors. Cell. 186(18). 3983–4002.e26.161 indexed citations breakdown →
7.
Suh, Susie, Elliot H. Choi, Aditya Raguram, David R. Liu, & Krzysztof Palczewski. (2022). Precision genome editing in the eye. Proceedings of the National Academy of Sciences. 119(39). e2210104119–e2210104119.33 indexed citations
Banskota, Samagya, Aditya Raguram, Susie Suh, et al.. (2022). Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins. Cell. 185(2). 250–265.e16.397 indexed citations breakdown →
10.
Davis, Jessie R., Xiao Wang, Isaac P. Witte, et al.. (2022). Efficient in vivo base editing via single adeno-associated viruses with size-optimized genomes encoding compact adenine base editors. Nature Biomedical Engineering. 6(11). 1272–1283.117 indexed citations breakdown →
11.
Neugebauer, Monica E., Alvin Hsu, Mandana Arbab, et al.. (2022). Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity. Nature Biotechnology. 41(5). 673–685.156 indexed citations breakdown →
12.
Mok, Beverly, Anna V. Kotrys, Aditya Raguram, et al.. (2022). CRISPR-free base editors with enhanced activity and expanded targeting scope in mitochondrial and nuclear DNA. Nature Biotechnology. 40(9). 1378–1387.131 indexed citations breakdown →
13.
Raguram, Aditya, Samagya Banskota, & David R. Liu. (2022). Therapeutic in vivo delivery of gene editing agents. Cell. 185(15). 2806–2827.318 indexed citations breakdown →
14.
Doman, Jordan L., Aditya Raguram, Gregory A. Newby, & David R. Liu. (2020). Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors. Nature Biotechnology. 38(5). 620–628.312 indexed citations breakdown →
15.
Lin, Qiupeng, Yuan Zong, Chenxiao Xue, et al.. (2020). Prime genome editing in rice and wheat. Nature Biotechnology. 38(5). 582–585.556 indexed citations breakdown →
16.
Mok, Beverly, Marcos H. de Moraes, Jun Zeng, et al.. (2020). A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing. Nature. 583(7817). 631–637.483 indexed citations breakdown →
Koblan, Luke W., Jordan L. Doman, Christopher Wilson, et al.. (2018). Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nature Biotechnology. 36(9). 843–846.662 indexed citations breakdown →
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.